305 related articles for article (PubMed ID: 20971705)
1. Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.
Beauvais DM; Rapraeger AC
J Cell Sci; 2010 Nov; 123(Pt 21):3796-807. PubMed ID: 20971705
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
[TBL] [Abstract][Full Text] [Related]
3. Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.
Rapraeger AC
FEBS J; 2013 May; 280(10):2207-15. PubMed ID: 23375101
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.
Beauvais DM; Ell BJ; McWhorter AR; Rapraeger AC
J Exp Med; 2009 Mar; 206(3):691-705. PubMed ID: 19255147
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
Yang N; Friedl A
PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth.
Beauvais DM; Jung O; Yang Y; Sanderson RD; Rapraeger AC
Cancer Res; 2016 Sep; 76(17):4981-93. PubMed ID: 27364558
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the α3β1 Integrin Via Binding Sites in Their Ectodomains: NOVEL SYNSTATINS PREVENT KINASE CAPTURE AND INHIBIT α6β4-INTEGRIN-DEPENDENT EPITHELIAL CELL MOTILITY.
Wang H; Jin H; Rapraeger AC
J Biol Chem; 2015 Oct; 290(43):26103-13. PubMed ID: 26350464
[TBL] [Abstract][Full Text] [Related]
8. Sdc1 negatively modulates carcinoma cell motility and invasion.
Ishikawa T; Kramer RH
Exp Cell Res; 2010 Apr; 316(6):951-65. PubMed ID: 20036233
[TBL] [Abstract][Full Text] [Related]
9. Interaction of syndecan and alpha6beta4 integrin cytoplasmic domains: regulation of ErbB2-mediated integrin activation.
Wang H; Leavitt L; Ramaswamy R; Rapraeger AC
J Biol Chem; 2010 Apr; 285(18):13569-79. PubMed ID: 20181947
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic domain interactions of syndecan-1 and syndecan-4 with α6β4 integrin mediate human epidermal growth factor receptor (HER1 and HER2)-dependent motility and survival.
Wang H; Jin H; Beauvais DM; Rapraeger AC
J Biol Chem; 2014 Oct; 289(44):30318-30332. PubMed ID: 25202019
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation.
Fujita M; Takada YK; Takada Y
J Biol Chem; 2013 Feb; 288(5):3059-69. PubMed ID: 23243309
[TBL] [Abstract][Full Text] [Related]
12. The NPIY motif in the integrin beta1 tail dictates the requirement for talin-1 in outside-in signaling.
Nieves B; Jones CW; Ward R; Ohta Y; Reverte CG; LaFlamme SE
J Cell Sci; 2010 Apr; 123(Pt 8):1216-26. PubMed ID: 20332112
[TBL] [Abstract][Full Text] [Related]
13. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling.
Saegusa J; Yamaji S; Ieguchi K; Wu CY; Lam KS; Liu FT; Takada YK; Takada Y
J Biol Chem; 2009 Sep; 284(36):24106-14. PubMed ID: 19578119
[TBL] [Abstract][Full Text] [Related]
14. Kindlin-2 (Mig-2): a co-activator of beta3 integrins.
Ma YQ; Qin J; Wu C; Plow EF
J Cell Biol; 2008 May; 181(3):439-46. PubMed ID: 18458155
[TBL] [Abstract][Full Text] [Related]
15. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
[TBL] [Abstract][Full Text] [Related]
16. The interaction of talin with the cell membrane is essential for integrin activation and focal adhesion formation.
Chinthalapudi K; Rangarajan ES; Izard T
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10339-10344. PubMed ID: 30254158
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 regulates cell migration and fibronectin fibril assembly.
Stepp MA; Daley WP; Bernstein AM; Pal-Ghosh S; Tadvalkar G; Shashurin A; Palsen S; Jurjus RA; Larsen M
Exp Cell Res; 2010 Aug; 316(14):2322-39. PubMed ID: 20580707
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTN
Stueven NA; Beauvais DM; Hu R; Kimple RJ; Rapraeger AC
Cancer Res Commun; 2023 Jan; 3(1):97-108. PubMed ID: 36968227
[TBL] [Abstract][Full Text] [Related]
19. Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with alphavbeta3 integrin that activates PKCalpha and RhoA.
Avalos AM; Valdivia AD; Muñoz N; Herrera-Molina R; Tapia JC; Lavandero S; Chiong M; Burridge K; Schneider P; Quest AF; Leyton L
J Cell Sci; 2009 Oct; 122(Pt 19):3462-71. PubMed ID: 19723805
[TBL] [Abstract][Full Text] [Related]
20. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y
J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
